Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: Finding new tools for an objective evaluation

Diabetology and Metabolic Syndrome

Volumn 4, Issue 1, 2012, Pages

  Valerio, Cynthia M ^a,d   Zajdenverg, Lenita ^b   De Oliveira, José Egídio P ^b   Mory, Patricia B ^c   Moyses, Regina S ^c   Godoy Matos, Amélio F ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d Instituto Estadual de Diabetes e Endocrinologia Luiz Capriglione   (Brazil)

Author keywords

Body composition; Dual Energy X ray Absorptiometry (DXA); Lipodystrophy

Indexed keywords

LEPTIN;

ADULT; BLOOD SAMPLING; BODY COMPOSITION; BODY FAT DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FAMILIAL PARTIAL LIPODYSTROPHY; FEMALE; HUMAN; INSULIN RESISTANCE; LEG; PATIENT SELECTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; TRUNK;

EID: 84865553862     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-4-40     Document Type: Review

References (22)

1. Acquired and Inherited Lipodystrophies. Garg A, N Engl J Med 2004 350 1220 1234 10.1056/NEJMra025261 15028826 (Pubitemid 38339366)
2. Garg A, Lipodystrophies. Am J Med 2000 108 143 152
3. Post-mortem findings in familial partial lipodistrophy, Dunnigan Variety. Haque WA, Vultch F, Garg A, Diabet Med 2002 19 12 1022 1025 10.1046/j.1464-5491.2002.00796.x 12647844 (Pubitemid 35471972)
4. Clinical review#: Lipodystrophies: genetic and acquired body fat disorders. Garg A, J Clin Endocrinol Metab 2011 96 11 3313 3325 10.1210/jc.2011-1159 21865368
5. Quantitative and qualitative differences in subcutaneous adipose tissue stores across lipodystrophy types shown by magnetic resonance imaging. Al-Atar S, Pollex RL, Robinson JF, BMC Medical Imaging 2007 7 3 10.1186/1471-2342-7-3 17352814 (Pubitemid 46502181)
6. Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan Variety). Garg A, Peshock RM, Fleckenstein JL, J Clin Endocrinol Metab 1999 84 170 174 10.1210/jc.84.1.170 9920078 (Pubitemid 29036696)
7. An imaging study of body composition including lipodeposition pattern in a patient of familial partial lipodystrophy (Dunnigan type). Pandey SN, Pungavkar SA, Vaidya RA, J Assoc Physicians India 2005 53 897 900 16459536 (Pubitemid 41406460)
8. Dual-Energy X-ray Absorptiometry Study of Body Composition in Patients with Lipodystrophy. Valerio CM, Godoy-Matos A, Moreira RO, Diab Care 2007 30 7 1857 1859 10.2337/dc07-0025 (Pubitemid 47036364)
9. A new method for body fat evaluation, body adiposity index, is useful in women with familial partial lipodystrophy. Godoy-Matos AF, Moreira RO, Valerio CM, Mory PB, Moises RS, Obesity 2012 20 2 440 443 10.1038/oby.2011.343 22095113
10. Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy. Bonnet E, Delpierre C, Sommet A, J Clin Densitom 2005 8 3 287 292 10.1385/JCD:8:3:287 16055958 (Pubitemid 41112844)
11. Longitudinal study of body composition of 10 HIV men with lipodystrophy: dual-energy X-ray criteria for clinical evolution. Degris E, Delpierre C, Sommet A, J Clin Densitom 2010 13 2 237 244 10.1016/j.jocd.2009.12.004 20347366
12. Fat mass ratio: an objective tool to define lipodystrophy in HIV-infected patients under antiretroviral therapy. Freitas P, Santos AC, Carvalho D, J Clin Densitom 2010 13 2 197 203 10.1016/j.jocd.2010.01.005 20347364
13. Phenotipic diversity in patients with lipodystrophy associated with LMNA mutations. Mory PB, Crispim F, Freire MB, Salles JE, Valério CM, Godoy-Matos AF, Dib SA, Moisés RS, Eur J Endocrinol 2012 167 3 423 431 10.1530/EJE-12-0268 22700598
14. Lower-body adiposity and metabolic protection in postmenopausal women. Van Pelt RE, Jankowski CM, Gozansky WS, Schwartz RS, Kohrt WM, J Clin Endocrinol Metab 2005 90 8 4573 4578 10.1210/jc.2004-1764 15886255 (Pubitemid 41159345)
15. Peripheral adiposity exhibits an independent dominant antiatherogeniceffect in elderly women. Tanko LB, Bagger YZ, Alexandersen P, Circulation 2003 107 1626 1631 10.1161/01.CIR.0000057974.74060.68 12668497 (Pubitemid 36397332)
16. Independent and opposite associations of hip and waist circumference with metabolic syndrome components and with inflammatory and atherothrombotic risk factors in overweight and obese women. Rocha PM, Barata JT, Teixeira PJ, Metabolism 2008 57 10 1315 1322 10.1016/j.metabol.2008.01.003 18803932
17. Familial partial lipodystrophy: Two types of an X linked dominant syndrome, lethal in the hemizygous state. Kobberling J, Dunnigan MG, J Med Genet. 1986 23 120 127 10.1136/jmg.23.2.120 3712389 (Pubitemid 16103193)
18. Partielle lipodystrophie mit lipatrophischem diabetes und hyperlipoproteinamie. Kobberling J, Schwarck H, Cremer P, Fiechtl J, Seidel D, Creutzfeldt W, Verh Dtsch Ges Inn Med. 1981 87 958 961
19. Kobberling type of familial partial lipodystrophy. Herbst K, Tannock LR, Deeb SS, Diab Care 2003 26 3 1819 1824
20. Lipodystrophies: windows on adipose biology and metabolism. Hegele RA, Joy TR, Al-Attar S, Rutt BK, Journal of Lipid Research 2007 48 1433 1444 10.1194/jlr.R700004-JLR200 17374881 (Pubitemid 47312005)
21. Leptin secretion from subcutaneous and visceral adipose tissue in women. Van Harmelen V, Reynisdottir S, Eriksson P, Diabetes 1998 47 913 917 10.2337/diabetes.47.6.913 9604868 (Pubitemid 28255665)
22. LMNA R482Q mutation associated with reduced plasma leptin concentration. Hegele RA, Cao H, Huff MW, J Clin Endocrinol Metab 2000 85 9 3089 3093 10.1210/jc.85.9.3089 10999791